Bio - Professor Michael Hofman is a nuclear medicine physician at the Centre for Molecular Imaging, Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia's only public hospital dedicated to cancer treatment, research and education. He has a co-appointment at the Univeristy of Melbourne and previously completed a fellowship at Guy's & St Thomas' hospital in London. He has particular interest in novel F-18 and Ga-68 PET radiotracers, and theranostic applications including neuroendocrine tumours and prostate cancer. He is currently the principal investigator of a multi-centre randomised clinical trial of PSMA PET and also several trials of Lu-177 PSMA therapy. He has authored over 100 peer-reviewed articles and several book chapters. He serves as a scientific member for the Australasian Radiopharmaceutical Trials Network (ARTnet) and an associate editor for several journals including Cancer Imaging, Leukaemia & Lymphoma, and the Journal of Medical Imaging and Radiation Oncology (JMIRO).